IRIS - Res&Arch Institutional Research Information System - Research & Archive

ROSSETTI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 509
EU - Europa 447
AS - Asia 63
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.021
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 509
SE - Svezia 127
UA - Ucraina 120
IE - Irlanda 71
IT - Italia 32
DE - Germania 29
CN - Cina 22
FI - Finlandia 22
HK - Hong Kong 22
RU - Federazione Russa 16
VN - Vietnam 14
GB - Regno Unito 13
BE - Belgio 7
CH - Svizzera 3
AT - Austria 2
BR - Brasile 1
EU - Europa 1
FR - Francia 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
SG - Singapore 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.021
Salva come PNG Salva come JPEG
Città #
Chandler 140
Dublin 71
Jacksonville 64
San Mateo 44
Ann Arbor 42
Hong Kong 22
Wilmington 20
Medford 19
Princeton 19
Andover 14
Dong Ket 14
Altamura 12
Lawrence 11
Woodbridge 11
Saint Petersburg 8
Beijing 7
Boardman 7
Brussels 7
Perugia 7
Los Angeles 5
Falls Church 4
San Paolo di Civitate 4
Auburn Hills 3
Des Moines 3
Helsinki 3
Norwalk 3
Amelia 2
Frankfurt Am Main 2
Houston 2
Nürnberg 2
Bucu 1
Den Haag 1
Hanover 1
Izmir 1
Moscow 1
Mountain View 1
Pacatuba 1
Rome 1
Seoul 1
Shanghai 1
Singapore 1
Totale 583
Salva come PNG Salva come JPEG
Nome #
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 111
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 89
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 70
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 68
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 61
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 60
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 60
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 50
null 49
Il nuovo analogo dell’insulina ad azione ritardata glargine: caratteristiche ed uso terapeutico nel diabete mellito 46
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 46
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 45
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 45
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 44
Glucagon: the effects of its excess and deficiency on insulin action 43
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 42
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 38
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 37
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 34
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin 15
Totale 1.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.459
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 6 2
2019/2020102 2 2 16 2 18 0 18 2 16 7 4 15
2020/2021252 1 20 18 17 55 24 19 2 36 14 26 20
2021/2022184 7 34 4 25 6 2 2 59 3 3 18 21
2022/2023328 21 64 3 41 33 37 0 16 105 0 7 1
2023/202472 7 19 4 2 1 0 15 0 8 1 15 0
Totale 1.053